[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3219316T3 - Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier - Google Patents

Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier Download PDF

Info

Publication number
DK3219316T3
DK3219316T3 DK17169929.1T DK17169929T DK3219316T3 DK 3219316 T3 DK3219316 T3 DK 3219316T3 DK 17169929 T DK17169929 T DK 17169929T DK 3219316 T3 DK3219316 T3 DK 3219316T3
Authority
DK
Denmark
Prior art keywords
mixture
treatment
acid group
fatty acid
inflammatory pathologies
Prior art date
Application number
DK17169929.1T
Other languages
English (en)
Inventor
Lodovico Burattin
Original Assignee
Again Life Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3219316(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl
Application granted granted Critical
Publication of DK3219316T3 publication Critical patent/DK3219316T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK17169929.1T 2013-03-08 2014-03-04 Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier DK3219316T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361774796P 2013-03-08 2013-03-08
IT000354A ITMI20130354A1 (it) 2013-03-08 2013-03-08 Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
EP14708015.4A EP2964215B1 (en) 2013-03-08 2014-03-04 Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (1)

Publication Number Publication Date
DK3219316T3 true DK3219316T3 (da) 2020-03-16

Family

ID=48227394

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17169929.1T DK3219316T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier
DK14708015T DK2964215T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14708015T DK2964215T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier

Country Status (18)

Country Link
US (2) US11020365B2 (da)
EP (2) EP2964215B1 (da)
AU (2) AU2014224710B2 (da)
CA (1) CA2904112C (da)
CY (2) CY1122248T1 (da)
DK (2) DK3219316T3 (da)
EA (2) EA035091B1 (da)
ES (2) ES2779851T3 (da)
HK (1) HK1243924A1 (da)
HR (2) HRP20191963T1 (da)
HU (2) HUE048361T2 (da)
IT (1) ITMI20130354A1 (da)
LT (2) LT2964215T (da)
PL (2) PL3219316T3 (da)
PT (2) PT2964215T (da)
RS (2) RS60023B1 (da)
SI (2) SI2964215T1 (da)
WO (1) WO2014135529A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
FI3177281T3 (fi) * 2014-08-08 2024-03-13 Ali Res S R L Rasvahappojen ja palmitoyylietanoliamidin seos käytettäväksi tulehduksellisten ja allergisten patologioiden hoitoon
AR102008A1 (es) * 2015-09-24 2017-01-25 Brix S R L Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
US20210205253A1 (en) * 2018-05-31 2021-07-08 The Asan Foundation Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis
KR102204097B1 (ko) * 2019-01-31 2021-01-18 동신대학교 산학협력단 지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
EP4103145A4 (en) * 2020-02-12 2024-07-03 Retrotope Inc DEUTERATED POLYUNSATURATED FATTY ACIDS OR THEIR ESTERS FOR COSMETIC APPLICATIONS
US12048681B2 (en) 2021-08-09 2024-07-30 Kentucky Equine Research, Inc. Compositions and methods for modulating equine fatty acid profiles
WO2023097296A1 (en) * 2021-11-24 2023-06-01 Jenivision Inc. Delivery methods for treating brain and central nervous system diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0637957T3 (da) * 1992-04-28 1997-08-18 Fresenius Ag Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
AU775774C (en) * 1999-04-15 2005-05-19 Kaneka Corporation Peroxisome proliferator-activated receptor agonist
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
DE10161729A1 (de) 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung
EP1358872B1 (de) 2002-04-30 2008-03-12 Cognis IP Management GmbH Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
JP2006520803A (ja) * 2003-03-20 2006-09-14 イマジェネティックス, インコーポレイテッド エステル化脂肪酸組成物
US20080057552A1 (en) * 2006-08-31 2008-03-06 Inmok Lee Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP4512881B2 (ja) * 2007-11-27 2010-07-28 築 中島 薬用油脂
WO2009117151A2 (en) * 2008-03-20 2009-09-24 Virun, Inc. Compositions containing non-polar compounds
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
WO2010049954A1 (en) * 2008-10-31 2010-05-06 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
WO2010118761A1 (en) 2009-04-17 2010-10-21 Eolas Science Limited Compositions rich in omega-3 fatty acids with a low content in phytanic acid
EP2796129B1 (en) * 2009-09-07 2015-06-17 Epitech Group S.r.l. Composition containing ultra - micronized palmitoyl - ethanolamide
CA2703532C (en) 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
DK2661266T3 (da) 2011-01-07 2020-11-16 Anji Pharma Us Llc Kemosensoriske receptorligandbaserede terapier
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Also Published As

Publication number Publication date
EA036724B1 (ru) 2020-12-11
PT2964215T (pt) 2019-11-12
US20160015666A1 (en) 2016-01-21
CY1122783T1 (el) 2021-05-05
CA2904112A1 (en) 2014-09-12
EP3219316B1 (en) 2020-02-19
LT2964215T (lt) 2019-11-25
EP2964215A1 (en) 2016-01-13
CY1122248T1 (el) 2020-11-25
ITMI20130354A1 (it) 2014-09-09
AU2014224710A1 (en) 2015-09-10
EP3219316A1 (en) 2017-09-20
PL2964215T3 (pl) 2020-03-31
SI3219316T1 (sl) 2020-07-31
HRP20200394T1 (hr) 2020-06-12
PL3219316T3 (pl) 2020-06-01
HRP20191963T1 (hr) 2020-01-24
RS60023B1 (sr) 2020-04-30
US20210290578A1 (en) 2021-09-23
SI2964215T1 (sl) 2019-12-31
EP2964215B1 (en) 2019-08-21
RS59523B1 (sr) 2019-12-31
CA2904112C (en) 2021-03-23
HUE048361T2 (hu) 2020-08-28
AU2018202190B2 (en) 2019-05-02
EA201591680A1 (ru) 2015-12-30
EA201791885A1 (ru) 2018-01-31
PT3219316T (pt) 2020-03-27
AU2018202190A1 (en) 2018-04-26
ES2779851T3 (es) 2020-08-20
WO2014135529A1 (en) 2014-09-12
HK1243924A1 (zh) 2018-07-27
US11020365B2 (en) 2021-06-01
LT3219316T (lt) 2020-04-10
ES2753257T3 (es) 2020-04-07
HUE046239T2 (hu) 2020-02-28
DK2964215T3 (da) 2019-11-11
AU2014224710B2 (en) 2018-04-12
EA035091B1 (ru) 2020-04-27

Similar Documents

Publication Publication Date Title
DK3219316T3 (da) Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier
DK3620534T3 (da) Crispr-cas sammensætninger af nucleinsyre-targeting nucleinsyrer
DK2970951T3 (da) Fremgangsmåder til nukleinsyresekventering
DK2970283T3 (da) Substituerede 2-aza-bicyclo[2.2.1]heptan-3-carboxylsyre-(benzyl-cyano-methyl)-amider som inhibitorer af cathepsin-c
DK2938740T3 (da) Kimære fgf19-peptider til anvendelse til behandling af galdesyrelidelser
BR112014030064A2 (pt) composição do ácido carboxílico.
DK3201320T3 (da) Højpotent sur alfa-glucosidase med forbedrede carbohydrater
DK3052641T3 (da) Fremgangsmåde til fremstilling af et hydrolysat af animalsk protein
BR112016013492A2 (pt) processo para a preparação de ácidos alcanossulfônicos.
DK3242903T3 (da) Sammensætninger til at indføre nukleinsyre i celler
RS62452B1 (sr) Insekticidni/miticidni sastav na bazi soli masnih kiselina
FR3001970B1 (fr) Procede de preparation d'acide 2,5-furane dicarboxylique
DK3166611T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer
DK3262161T3 (da) Rekombinante værtsceller til fremstilling af 3-hydroxypropionsyre
DK3097910T3 (da) Antiinflamatorisk middel indeholdende sjælden fedtsyre
DK3305755T3 (da) Ny fremgangsmåde til at fremstille stærkt umættede fedtsyreestere
DK3082795T3 (da) Sammensætninger af omega 3 fedtsyrer til behandling af sygdomme, der involverer skader på nervesystemet
FR3027522B1 (fr) Composition poreuse chargee en principe actif
FI20150044A (fi) Rasvahappokoostumus
EP3093285A4 (en) Gadolinium complex comprising do3a-tranexamic acid conjugate
DK2977459T3 (da) Fremgangsmåde til fremstilling af 5-aminolevulinsyre eller salt deraf
FI20136135A (fi) Menetelmä hartsipitoisen rasvahapposaippuan valmistamiseksi, rasvahapposaippuakoostumus sekä sen käyttö
DK3533791T3 (da) Fremgangsmåde til fremstilling af 3-methyl-2-thiophencarboxylsyre
TH1501005077A (th) การใช้กรดซัลโฟนิกสำหรับการนำกลับคืนมาของกลีเซอรอลที่ได้ผล มาจากปฏิกิริยาทรานสเอสเทอริฟิเคชั่นของไตรกลีเซอไรด์
HK1224500A2 (zh) 用於黏膜斷裂的磺酸製劑